United States · Bill · HR
H.R. 3066 (107th)
Ephedrine Alkaloid Consumer Protection Act
Introduced
9 October 2001
Last action
—
Status
Referred to the Subcommittee on Health.
Sponsors
—
Subjects
Discovery layer
Source updated
19 August 2025
Summary
Ephedrine Alkaloid Consumer Protection Act - Amends the Federal Food, Drug, and Cosmetic Act to provide that if a dietary supplement contains ephedrine alkaloids, it will be misbranded if: (1) its labeling and advertising fails to contain a specified warning; or (2) the sale of the supplement is made to an individual under the age of 18, or in the case of a sale at retail, the purchaser has direct access to the supplement at the retail establishment involved, rather than the supplement being held at a portion of the establishment not intended to be accessible to customers of the establishment.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 9 October 2001
Introduced in House (PDF)
Introduced in House · EN · 9 October 2001
Introduced in House
summary · EN · 9 October 2001
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/107th-congress/house-bill/3066
- Open data entity: https://api.congress.gov/v3/bill/107/hr/3066